Roberto Mina, assistant professor in the Department of Hematology and Medical Oncology at Emory University School of Medicineshared a post on X:
“Join the crew in Chicago for ASCO2026.
You’ll hear about Tec and the Majestec-9 data from me in early RRMM, 5-y sustained MRD in the FORTE study from Mattia D’Agostino and the new IMS risk definition applied to EMN17/PERSEUS from Luca Bertamini.”
Other articles about ASCO on OncoDaily.